Literature DB >> 11026456

Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G.

H Wiendl1, L Behrens, S Maier, M A Johnson, E H Weiss, R Hohlfeld.   

Abstract

We demonstrate that HLA-G, a nonclassical major histocompatibility complex class I antigen, is expressed in muscle fibers in various inflammatory myopathies. Further, interferon-gamma induces surface expression and upregulation of mRNA transcripts corresponding to different isoforms of HLA-G in myoblasts cultured from control subjects and patients. HLA-G may have important immunological functions in inflammatory myopathies and other local immune reactions as they occur during vaccination, myoblast transplantation, and gene therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11026456

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

1.  Modulation of HLA-G expression in human neural cells after neurotropic viral infections.

Authors:  Monique Lafon; Christophe Prehaud; Françoise Megret; Mireille Lafage; Gaël Mouillot; Michèle Roa; Philippe Moreau; Nathalie Rouas-Freiss; Edgardo D Carosella
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 2.  HLA class Ib in pregnancy and pregnancy-related disorders.

Authors:  Gry Persson; Wenna Nascimento Melsted; Line Lynge Nilsson; Thomas Vauvert F Hviid
Journal:  Immunogenetics       Date:  2017-07-11       Impact factor: 2.846

3.  Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages.

Authors:  Frédéric Gros; Yasmine Sebti; Sophie de Guibert; Bernard Branger; Marc Bernard; Renée Fauchet; Laurence Amiot
Journal:  Neoplasia       Date:  2006-03       Impact factor: 5.715

4.  A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.

Authors:  Bruce A C Cree; John D Rioux; Jacob L McCauley; Pierre-Antoine F D Gourraud; Philippe Goyette; Joseph McElroy; Philip De Jager; Adam Santaniello; Timothy J Vyse; Peter K Gregersen; Daniel Mirel; David A Hafler; Jonathan L Haines; Margaret A Pericak-Vance; Alastair Compston; Stephen J Sawcer; Jorge R Oksenberg; Stephen L Hauser
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

5.  HLA-G does not have a pathophysiological role in Graves' disease.

Authors:  E H Kemp; R A Metcalfe; P F Watson; A P Weetman
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

6.  Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammation.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Cristiano Jodicke; Shali Mazaki-Tovi; Edi Vaisbuch; Offer Erez; Pooja Mittal; Francesca Gotsch; Tinnakorn Chaiworapongsa; Sam S Edwin; Percy Pacora; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-12

7.  Interferon-γ restricts Toxoplasma gondii development in murine skeletal muscle cells via nitric oxide production and immunity-related GTPases.

Authors:  Anna C Takács; Izabela J Swierzy; Carsten G K Lüder
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

8.  Tolerogenic function of dimeric forms of HLA-G recombinant proteins: a comparative study in vivo.

Authors:  Benoit Favier; Kiave-Yune HoWangYin; Juan Wu; Julien Caumartin; Marina Daouya; Anatolij Horuzsko; Edgardo D Carosella; Joel LeMaoult
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

9.  Inclusion body myositis: laser microdissection reveals differential up-regulation of IFN-γ signaling cascade in attacked versus nonattacked myofibers.

Authors:  Jana Ivanidze; Reinhard Hoffmann; Hanns Lochmüller; Andrew G Engel; Reinhard Hohlfeld; Klaus Dornmair
Journal:  Am J Pathol       Date:  2011-09       Impact factor: 4.307

10.  Heparin increases HLA-G levels in primary antiphospholipid syndrome.

Authors:  Jozélio Freire de Carvalho; Ricardo M de Oliveira; Carlos Ewerton Maia Rodrigues; Andréa Glezer; Eloísa Bonfá; Rosa Maria Rodrigues Pereira
Journal:  Clin Dev Immunol       Date:  2012-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.